- Myeloproliferative disorders and pregnancy: obstetric and perinatal aspects
Myeloproliferative disorders and pregnancy: obstetric and perinatal aspects
PERINATOLOGY AND PEDIATRIC. UKRAINE. 2018.3(75):52-55; doi 10.15574/PP.2018.75.52
Naumchyk A. N., Davydova Iu. V.
SI «Istitute of Pediatrics, Obstetrics and Gynecology by academician O.M. Lukyanova of NAMS of Ukraine», Kyiv
Objective: to study the management features of pregnant women with myelodysplastic syndrome; to elaborate recommendations on the preconceptional preparation and management of pregnancy in this group of women.
Materials and methods. The data of English$language literature (PubMed, Medline, Cochrane library, Google Search) for 10 years on myeloproliferative disorders, essential thrombocythaemia, and pregnancy have been analysed. In total there were found 230 publications. The most relevant information was obtained from two sources. The content analysis was used.
Results and conclusions. Pregnancy in women with myeloproliferative disorders requires thoughtful planning at the preconceptional stage, pregravid preparation, and also at the stages of pregnancy management, delivery and the postpartum period, considering a substantial number of complications. The most probable complications are thromboembolic ones. The issue of anticoagulant, antiplatelet therapy has been considered.
Key words: myeloproliferative disorders, essential thrombocythaemia, pregnancy.
1. Rukavitsyin OA, Pop VP. (2004). Hronicheskie leykozyi. Moskva: Binom. Laboratoriya znaniy: 44–81.
2. Barbui T, Thiele J, Gisslinger H, Kvasnicka HM, Vannucchi AM, Guglielmelli P, Orazi A, Tefferi A. (2018, Feb.). The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in!depth discussion. Blood Cancer J. 8(2): 15. https://doi.org/10.1038/s41408-018-0054-y; PMid:29426921 PMCid:PMC5807384
3. Bohiltea RE, Cirstoiu MM, Ionescu CA, Niculescu-Mizil E, Vladareanu AM, Voican I, Dimitriu M, Turcan N. (2017, Nov). Primary myelofibrosis and pregnancy outcomes after low molecular!weight heparin administration: A case report and literature review. Medicine (Baltimore). 96(46). https://doi.org/10.1097/MD.0000000000008735; PMid:29145319 PMCid:PMC5704864
4. Kleman A, Singavi AK, Michaelis LC. (2017, Oct). Current challenges in the management of essential thrombocythemia. Clin Adv Hematol Oncol. 15(10): 773–783. PMid:29040257
5. Lapoirie J, Contis A, Guy A, Lifermann F, Viallard JF, Sentilhes L, James C, Duffau P. (2018, Jun). Management and outcomes of 27 pregnancies in women with myeloproliferative neoplasms. J Matern Fetal Neonatal Med. 26: 1–8. https://doi.org/10.1080/14767058.2018.1484097; PMid:29945475
6. Pavord S, Hunt B. (2010). The obstetric hematology manual. New York: 266. https://doi.org/10.1017/CBO9780511676451
Article received: Jun 16, 2018. Accepted for publication: Sep 01, 2018.